Diagnostic confusion resulting from CD56 expression by cutaneous myeloid sarcoma
暂无分享,去创建一个
[1] C. Ross,et al. TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis , 2007, Modern Pathology.
[2] S. Pileri,et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients , 2007, Leukemia.
[3] C. Massone,et al. CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer , 2006, Journal of Clinical Pathology.
[4] C. Meijer,et al. CD 56 1 hematological neoplasms presenting in the skin : a retrospective analysis of 23 new cases and 130 cases from the literature , 2004 .
[5] M. Ueda,et al. Myeloid markers should be undertaken in cases of CD56 positivity to exclude granulocytic sarcoma , 2002, The British journal of dermatology.
[6] P. Mahendra,et al. Chloroma (aleukaemic leukaemia cutis) initially diagnosed as cutaneous lymphoma , 2002, Clinical and experimental dermatology.
[7] P. Tai,et al. Merkel Cell Carcinoma of the Skin , 2000, Journal of cutaneous medicine and surgery.
[8] 鈴木 律朗. CD7[+] and CD56[+] myeloid/natural killer cell precursor acute leukemia : a distinct hematolymphoid disease entity , 1998 .
[9] K. Smith,et al. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. , 1997, Journal of the American Academy of Dermatology.
[10] J. Chan,et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. , 1997, Blood.